April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
HMW FGF-2 Mediates Cell Rescue After Retroviral Gene Transfer to Human Corneal Endothelial Cells
Author Affiliations & Notes
  • K. Engelmann
    Ophthalmology, Klinikum Chemnitz, Chemnitz, Germany
    CRTD / DFG-Center for Regenerative Therapies Dresden - Cluster of Excellence, Dresden, Germany
  • M. Valtink
    Anatomy,
    TU Dresden, Medical Faculty, Dresden, Germany
  • D. Lindemann
    CRTD / DFG-Center for Regenerative Therapies Dresden - Cluster of Excellence, Dresden, Germany
    Virology,
    TU Dresden, Medical Faculty, Dresden, Germany
  • R. H. W. Funk
    CRTD / DFG-Center for Regenerative Therapies Dresden - Cluster of Excellence, Dresden, Germany
    Anatomy,
    TU Dresden, Medical Faculty, Dresden, Germany
  • Footnotes
    Commercial Relationships  K. Engelmann, None; M. Valtink, None; D. Lindemann, None; R.H.W. Funk, None.
  • Footnotes
    Support  supported by MeDDrive (Medical Faculty Research Funding Program, TU Dresden) and CRTD / DFG-Center for Regenerative Therapies Dresden - Cluster of Excellence
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1732. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Engelmann, M. Valtink, D. Lindemann, R. H. W. Funk; HMW FGF-2 Mediates Cell Rescue After Retroviral Gene Transfer to Human Corneal Endothelial Cells. Invest. Ophthalmol. Vis. Sci. 2009;50(13):1732.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate retroviral vectors as a tool to transduce primary human corneal endothelial cells (pHCEC) and to assess a possible role of HMW FGF-2 in HCEC proliferation and survival. Such method may be applied to detect factors that are able to induce an increase in corneal endothelial cell density of insufficient donor corneas, hence increasing the number of available corneas for keratoplasty.

Methods: : Retroviral vectors based on HIV-1 and MLV, both pseudotyped with either VSV-G env or FV env, were tested upon their infectivity in primary human corneal endothelial cells (pHCEC). HIV-1 based vectors which express either 18 kD FGF-2 or codon-optimized 22 kD, 22.5 kD, 24 kD or 34 kD isoforms of human FGF-2 were generated. Viruses were produced in 293T cells using a three plasmid system. Transduction efficiency was evaluated and optimized for pHCEC by FACS, and FGF-2 expression was assessed by western blotting. HT1080 epithelial cells and NIH 3T3 fibroblasts served as control cells. Toxic effect of virus infection under starvation or enriched nutrient conditions and cell survival mediated by FGF-2 overexpression were evaluated by means of resazurin conversion test.

Results: : HIV-1 based vectors appeared superior to MLV based vectors, and FV env appeared superior to VSV-G env, with gene transfer efficiencies >90 % in pHCEC (average titers 106-107). Transduction with FGF-2 resulted in overexpression of the respective isoform in all tested cell populations. It was also found that cultured pHCEC expressed the 18, 22.5 and 24 kD isoform constituently. Nuclear localization of the 22 - 34 kD isoforms was proven by western blotting after mild cell lysis (excluding nuclei) versus total cell lysis. Resazurin conversion test revealed a toxic effect of viral infection on pHCEC. FGF-2 overexpression especially of the higher molecular weight isoforms partially abolished this effect and was also found to promote cell survival under serum-free and starvation culture conditions.

Conclusions: : Retroviral vectors can efficiently be used to transduce pHCEC. HMW FGF-2 is a potent survival factor in pHCEC.

Keywords: cornea: endothelium • gene transfer/gene therapy • growth factors/growth factor receptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×